CeriBell, Inc./$CBLL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CeriBell, Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Ticker
$CBLL
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
281
ISIN
US15678C1027
Website
CeriBell, Inc. Metrics
BasicAdvanced
$592M
-
-$2.29
-
-
Price and volume
Market cap
$592M
52-week high
$25.37
52-week low
$10.01
Average daily volume
340K
Financial strength
Current ratio
17.363
Quick ratio
16.398
Long term debt to equity
11.411
Total debt to equity
12.029
Interest coverage (TTM)
-22.42%
Profitability
EBITDA (TTM)
-44.244
Gross margin (TTM)
87.25%
Net profit margin (TTM)
-62.50%
Operating margin (TTM)
-63.55%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on equity (TTM)
-41.39%
Valuation
Price to revenue (TTM)
4.478
Price to book
3.25
Price to tangible book (TTM)
3.25
Price to free cash flow (TTM)
-8.29
Free cash flow yield (TTM)
-12.06%
Free cash flow per share (TTM)
-197.59%
Growth
Revenue change (TTM)
44.86%
Earnings per share change (TTM)
-60.38%
Bulls say / Bears say
Ceribell reported Q1 2025 revenue of $20.5 million, a 42% increase compared to Q1 2024, indicating strong growth momentum. (stocktitan.net)
The company received FDA 510(k) clearance for its pediatric Clarity™ algorithm, expanding its market reach to younger patients. (stocktitan.net)
Ceribell achieved FedRAMP High authorization, allowing its AI-powered EEG system to be implemented across federal healthcare facilities, including VA hospitals. (stocktitan.net)
The company reported a net loss of $12.8 million in Q1 2025, an increase from the $8.5 million net loss in Q1 2024, raising concerns about profitability. (stocktitan.net)
Insider selling activity, including the CEO selling shares in April 2025, may signal potential concerns about the company's future performance. (americanbankingnews.com)
Despite revenue growth, the company's operating cash flow remains negative, indicating ongoing challenges in achieving operational profitability. (stocktitan.net)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
CeriBell, Inc. News
AllArticlesVideos
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
GlobeNewsWire·1 week ago
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewsWire·2 months ago
Ceribell Reports First Quarter 2025 Financial Results
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CeriBell, Inc. stock?
CeriBell, Inc. (CBLL) has a market cap of $592M as of July 16, 2025.
What is the P/E ratio for CeriBell, Inc. stock?
The price to earnings (P/E) ratio for CeriBell, Inc. (CBLL) stock is 0 as of July 16, 2025.
Does CeriBell, Inc. stock pay dividends?
No, CeriBell, Inc. (CBLL) stock does not pay dividends to its shareholders as of July 16, 2025.
When is the next CeriBell, Inc. dividend payment date?
CeriBell, Inc. (CBLL) stock does not pay dividends to its shareholders.
What is the beta indicator for CeriBell, Inc.?
CeriBell, Inc. (CBLL) does not currently have a Beta indicator.